PRF1 and myeloid sarcoma: At the 2012 meeting of the Society for Natural Immunity, we presented experimental results from a cross sectional study indicating that untreated MS patients had a relative deficiency of CD16+Perforin+ NK cells relative to apparently healthy controls (Nayak and Jacolik, 2012).